Travere Therapeutics, Inc.
Travere Therapeutics, Inc. (TVTX) is a publicly traded company in the Unknown sector. Across all available filings, 21 corporate insiders have executed 320 transactions totaling $27.5M, demonstrating a bearish sentiment with -$27.5M in net insider flow. The most recent transaction on Feb 3, 2026 involved a sale of 7,175 shares valued at $230.5K.
TVTX Insider Activity Summary
Who Is Buying TVTX Stock?
No significant insider buying has been recorded for TVTX in the recent period.
Who Is Selling TVTX Stock?
No significant insider selling has been recorded for TVTX in the recent period.
Is Travere Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for TVTX is bearish with an Insider Alignment Score of 0/100 and a net flow of -$27.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
TVTX Frequently Asked Questions
Understanding TVTX Insider Activity
Insider trading at Travere Therapeutics, Inc. (TVTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 21 insiders are actively trading TVTX stock, having executed 320 transactions in the past 90 days. The most active insider is Eric M. Dube (Executive), who has made 43 transactions totaling $11.3M.
Related Tools
Track Travere Therapeutics, Inc. Insider Activity
Get notified when executives and directors at TVTX file new Form 4 transactions